This inventor holds 6 USPTO granted patents. Top assignees: Transgene S.a., Pasteur Merieux Serums Et Vaccins, Other. Active years: 1998-2013.
Location History:
- Dorlisheim, FR (1998 - 2002)
- Stotzheim, FR (2013)
Company Filing History:
4 out of 159 
1 out of 16 
2 out of 834,411 Years Active: 1998-2013
Title: Eric Jacobs: Innovator in Peptide Technology
Introduction
Eric Jacobs is a notable inventor based in Dorlisheim, France. He has made significant contributions to the field of peptide technology, holding a total of 6 patents. His work focuses on novel peptides and their applications in various biological processes.
Latest Patents
One of his latest patents involves signaling peptides. This invention provides novel peptides of specified sequences and their use as signal peptides or membrane-anchoring peptides. It also relates to chimeric polypeptides that comprise one or more such peptides along with a polypeptide of interest. Additionally, it includes nucleic acid molecules, vectors, viral particles, and host cells encoding these peptides and chimeric polypeptides. The invention further describes a pharmaceutical composition that includes these elements and a pharmaceutically acceptable vehicle. Moreover, it provides a method for producing a polypeptide using these peptides, particularly for directing the expression of a polypeptide of interest either extracellularly or anchored at the surface of the plasma membrane.
Another significant patent is a cassette for expressing a Toxoplasma gondii P30 protein. This invention provides a reagent for detecting or monitoring an infection, which includes a truncated P30 protein. This protein has had all of the hydrophobic C-terminal region of the native protein deleted, while retaining the region of the native protein that starts with amino acid 31 and ends with amino acid 299. The invention also describes methods for screening anti-Toxoplasma antibodies in biological samples.
Career Highlights
Eric Jacobs has worked with Transgene S.A., a company known for its innovative approaches in biotechnology. His experience in this company has contributed to his expertise in peptide technology and its applications.
Collaborations
Throughout his career, Eric has collaborated with notable colleagues such as Bernadette Bouchon-Theisen and Nathalie Silvestre. These collaborations have likely enriched his research and development efforts in the field.
Conclusion
Eric Jacobs is a prominent inventor whose work in peptide technology has led to significant advancements in the field. His innovative patents and collaborations highlight his contributions to science and medicine.